Balchem Corporation (BCPC)
Price:
165.12 USD
( + 3.19 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Linde plc
VALUE SCORE:
7
2nd position
WD-40 Company
VALUE SCORE:
8
The best
Gevo, Inc.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
NEWS
Balchem (BCPC) Surpasses Q2 Earnings and Revenue Estimates (Revised)
zacks.com
2025-08-01 16:16:05Balchem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.
Balchem (BCPC) Q2 EPS Jumps 16.5%
fool.com
2025-08-01 06:18:45Balchem (BCPC 0.24%), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue and non-GAAP profits, well surpassing analyst expectations for Q2 FY2025.
Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-01 04:27:08Balchem Corporation (NASDAQ:BCPC ) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Lee Harris - CEO, President & Chairman Conference Call Participants Anthony Polak - Unidentified Company Aegis Capital Corp. - Unidentified Company Daniel Scott Harriman - Sidoti & Company, LLC Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Robert James Labick - CJS Securities, Inc. Operator Ladies and gentlemen, thank you for standing by.
Blachem (BCPC) Surpasses Q2 Earnings and Revenue Estimates
zacks.com
2025-07-31 09:16:13Blachem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.
Balchem Corporation Reports Second Quarter 2025 Financial Results
globenewswire.com
2025-07-31 07:00:00MONTVALE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025.
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025
globenewswire.com
2025-07-17 07:00:00MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results.
Balchem Corporation: The Next Earnings Release Should Guide Investors
seekingalpha.com
2025-07-14 17:43:44Balchem operates in diverse specialty ingredient markets, maintaining steady growth and a market cap of $5.3B. Revenue per share has grown 6% annually over a decade, but recent growth has plateaued, warranting close monitoring. Gross profit margin has improved significantly, rising from 30% to over 35% in the latest fiscal year.
Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025
globenewswire.com
2025-06-26 07:00:00MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Annual New Ideas Summer Conference on July 10, 2025.
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025
globenewswire.com
2025-05-28 07:00:00MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025.
Balchem Corporation to Participate in the dbAccess Global Consumer Conference on June 4, 2025
globenewswire.com
2025-05-21 07:00:00MONTVALE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the dbAccess Global Consumer Conference on June 4, 2025.
Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-04-24 18:52:21Balchem Corporation (NASDAQ:BCPC ) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Participants Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's First Quarter 2025 Earnings Conference Call.
Blachem (BCPC) Lags Q1 Earnings Estimates
zacks.com
2025-04-24 09:20:53Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago.
Blachem (BCPC) Upgraded to Strong Buy: Here's Why
zacks.com
2025-04-11 13:05:33Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025
globenewswire.com
2025-04-11 07:00:00MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results.
Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025
globenewswire.com
2025-02-25 07:00:00MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025.
Balchem Is A Great Company, But I'm Still Waiting For A Better Entry
seekingalpha.com
2025-02-24 12:00:38Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors.
Balchem (BCPC) Surpasses Q2 Earnings and Revenue Estimates (Revised)
zacks.com
2025-08-01 16:16:05Balchem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.
Balchem (BCPC) Q2 EPS Jumps 16.5%
fool.com
2025-08-01 06:18:45Balchem (BCPC 0.24%), a leading provider of nutritional ingredients and specialty chemicals, released its second quarter results on July 31, 2025. The key news: Balchem reported record GAAP revenue and non-GAAP profits, well surpassing analyst expectations for Q2 FY2025.
Balchem Corporation (BCPC) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-01 04:27:08Balchem Corporation (NASDAQ:BCPC ) Q2 2025 Earnings Conference Call July 31, 2025 11:00 AM ET Company Participants Carl Martin Bengtsson - Executive VP, CFO, Treasurer and GM of Animal Nutrition & Health Theodore Lee Harris - CEO, President & Chairman Conference Call Participants Anthony Polak - Unidentified Company Aegis Capital Corp. - Unidentified Company Daniel Scott Harriman - Sidoti & Company, LLC Raghuram Selvaraju - H.C. Wainwright & Co, LLC, Research Division Robert James Labick - CJS Securities, Inc. Operator Ladies and gentlemen, thank you for standing by.
Blachem (BCPC) Surpasses Q2 Earnings and Revenue Estimates
zacks.com
2025-07-31 09:16:13Blachem (BCPC) came out with quarterly earnings of $1.27 per share, beating the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.98 per share a year ago.
Balchem Corporation Reports Second Quarter 2025 Financial Results
globenewswire.com
2025-07-31 07:00:00MONTVALE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2025 fiscal second quarter ended June 30, 2025.
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025
globenewswire.com
2025-07-17 07:00:00MONTVALE, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, July 31, 2025, at 11:00 AM Eastern Time (ET) to review second quarter 2025 results.
Balchem Corporation: The Next Earnings Release Should Guide Investors
seekingalpha.com
2025-07-14 17:43:44Balchem operates in diverse specialty ingredient markets, maintaining steady growth and a market cap of $5.3B. Revenue per share has grown 6% annually over a decade, but recent growth has plateaued, warranting close monitoring. Gross profit margin has improved significantly, rising from 30% to over 35% in the latest fiscal year.
Balchem Corporation to Present at the CJS Annual New Ideas Summer Conference on July 10, 2025
globenewswire.com
2025-06-26 07:00:00MONTVALE, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the CJS Annual New Ideas Summer Conference on July 10, 2025.
Balchem Corporation to Present at the Wells Fargo Industrials and Materials Conference on June 11, 2025
globenewswire.com
2025-05-28 07:00:00MONTVALE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the Wells Fargo Industrials and Materials Conference on June 11, 2025.
Balchem Corporation to Participate in the dbAccess Global Consumer Conference on June 4, 2025
globenewswire.com
2025-05-21 07:00:00MONTVALE, N.J., May 21, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the dbAccess Global Consumer Conference on June 4, 2025.
Balchem Corporation (BCPC) Q1 2025 Earnings Call Transcript
seekingalpha.com
2025-04-24 18:52:21Balchem Corporation (NASDAQ:BCPC ) Q1 2025 Earnings Conference Call April 24, 2025 11:00 AM ET Company Participants Martin Bengtsson - CFO Ted Harris - Chairman, President & CEO Conference Call Participants Ram Selvaraju - H.C. Wainwright & Co Daniel Harriman - Sidoti & Company Operator Greetings, and welcome to Balchem's First Quarter 2025 Earnings Conference Call.
Blachem (BCPC) Lags Q1 Earnings Estimates
zacks.com
2025-04-24 09:20:53Blachem (BCPC) came out with quarterly earnings of $1.22 per share, missing the Zacks Consensus Estimate of $1.25 per share. This compares to earnings of $0.89 per share a year ago.
Blachem (BCPC) Upgraded to Strong Buy: Here's Why
zacks.com
2025-04-11 13:05:33Blachem (BCPC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Balchem Corporation Announces Quarterly Conference Call for First Quarter 2025 Financial Results on April 24, 2025
globenewswire.com
2025-04-11 07:00:00MONTVALE, N.J., April 11, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Thursday, April 24, 2025, at 11:00 AM Eastern Time (ET) to review first quarter 2025 results.
Balchem Corporation to Participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025
globenewswire.com
2025-02-25 07:00:00MONTVALE, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the BNP Paribas Exane 13th Consumer Ingredients Conference on March 11, 2025.
Balchem Is A Great Company, But I'm Still Waiting For A Better Entry
seekingalpha.com
2025-02-24 12:00:38Balchem Corporation specializes in performance ingredients across nutrition, food, pharmaceuticals, and animal health, but its high P/E ratio and rising costs warrant a "Hold" rating. Q4 2024 saw modest revenue growth of 4.9%, with notable gains in GAAP earnings (23.8%) and adjusted EBITDA (13.4%), driven by strong Human Nutrition & Health performance. Despite growth in key segments, Balchem's high valuation and macroeconomic pressures suggest waiting for a more attractive entry point for new investors.